The structural basis of drugs targeting protein-protein interactions uncovered with the protein-ligand interaction profiler PLIP
Preprint
Abstract
Promiscuity of drugs and targets plays an important role in drug-target prediction, ranging from the explanation of side effects to their exploitation in drug repositioning. A specific form of promiscuity concerns drugs, which interfere with protein-protein interactions. With the rising importance of such drugs in drug discovery and with the large-scale availability of structural data, the question arises on the structural basis of this form of promiscuity and the commonalities of the underlying protein-ligand (PLI) and protein-protein interactions (PPI). To this end, we employ the protein-ligand interaction profiler, PLIP, to characterize the PLI and PPI of MDM2/p53, Bcl-2/BAX, XIAP/Casp9, CCR5/gp120, and BRD/H4. We show that the wealth of existing complexes in PDB, of predicted protein structures, and of molecular docking results gives deep insights into the design principles for drugs targeting protein interactions. Drugs targeting protein interaction interfaces are a promising avenue in drug discovery. Understanding drug and target promiscuity at a structural level will pave the way to deliver on this promise.Keywords
All Related Versions
- Published version: Expert Opinion on Drug Discovery, 20 (11), 1447.
This publication has 64 references indexed in Scilit:
- Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitorComputational and Structural Biotechnology Journal, 2021
- Drug repurposing approach to fight COVID-19Pharmacological Reports, 2020
- Remdesivir: First ApprovalDrugs, 2020
- Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface areaCurrent Opinion in Chemical Biology, 2018
- Putting p53 in ContextCell, 2017
- ChemInform Abstract: Structure‐Based Design of Inhibitors of Protein—Protein Interactions: Mimicking Peptide Binding EpitopesChemInform, 2015
- Compound promiscuity: what can we learn from current data?Drug Discovery Today, 2013
- Hot spots—A review of the protein–protein interface determinant amino‐acid residuesProteins: Structure, Function, and Bioinformatics, 2007
- N-H…O, O-H…O, and C-H…O hydrogen bonds in protein–ligand complexes: Strong and weak interactions in molecular recognitionProteins: Structure, Function, and Bioinformatics, 2003
- Dissecting protein–protein recognition sitesProteins: Structure, Function, and Bioinformatics, 2002